Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

17.50
Delayed Data
As of Aug 18
 -0.06 / -0.34%
Today’s Change
4.03
Today|||52-Week Range
21.85
+60.40%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Schmertzler Michael
Director
Buy9/23/201660,000$10.85$651.0K+50.09%
Svoronos Dawn
Director
Buy5/23/201725,000$13.49$337.3K+29.63%
Kovacs Shane William Charles
Chief Financial Officer
Buy5/09/201710,000$10.85$108.5K+48.56%
Kovacs Shane William Charles
Chief Financial Officer
Buy9/26/201610,000$10.85$108.5K+50.34%
Almstead Neil Gregory
Buy9/27/20166,586$10.85$71.5K+47.31%
Almstead Neil Gregory
Buy9/27/20163,414$10.85$37.0K+47.31%
Rothera Mark A
Chief Commercial Officer
Buy1/17/20173,125$10.85$33.9K+18.97%
Rothera Mark A
Chief Commercial Officer
Buy2/16/20173,125$10.85$33.9K+27.00%
Rothera Mark A
Chief Commercial Officer
Buy3/15/20172,966$10.85$32.2K+60.55%
Rothera Mark A
Chief Commercial Officer
Buy9/26/20162,200$10.85$23.9K+50.34%
Page of 3